Skip to content
value.today
Pharmadax logo

Pharmadax

4191.TWOUnlisted company
$98 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

More about Pharmadax

Acquisitions and changes
No longer listed: it is not in the Taiwan Stock Exchange's register of listed companies or the Taipei Exchange's registers of OTC and emerging-board companies (checked 14 November 2026).

Market cap history

$0 M$26 M$53 M$79 M$106 M202020212022

World rank over time

▼ down 3,432 places since 2020
2020-01-01: #19687#19,68720202022-01-07: #23119#23,1192022

Rank in Taiwan: #1,026 (Jan 2020) · #1,187 (Jan 2022)

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Pharmadax🇹🇼$98 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 7, 2022 (last known)
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Pharmadax? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Pharmadax's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Pharmadax? Suggest a correction